期刊文献+

MIC-1和uPA蛋白在皮肤鳞状细胞癌组织中的表达及与组织学分级和发病部位的关系 被引量:3

Expression of MIC-1 and uPA Protein in Cutaneous Squamous Cell Carcinoma and Their Correlation with Histological Grade,Location
下载PDF
导出
摘要 目的 探讨MIC-1和uPA蛋白在皮肤鳞状细胞癌中的表达及与组织学分级和发病部位的关系。方法 应用免疫组化SP法检测42例皮肤鳞状细胞癌组织及42例正常对照皮肤中MIC-1及uPA蛋白的表达,并分析其与组织学分级及发病部位的关系。结果 皮肤鳞状细胞癌组织中MIC-1(66.67%)及uPA蛋白(78.57%)阳性表达率均显著高于正常对照皮肤组织中的阳性表达率(16.67%和28.57%),差异均有统计学意义(P均<0.05);皮肤鳞状细胞癌组织中MIC-1及uPA蛋白阳性表达率均与鳞状细胞癌病理组织学分级密切相关(P均<0.05);MIC-1与uPA蛋白的表达呈正相关(P<0.05)。结论 皮肤鳞状细胞癌组织中MIC-1和uPA蛋白的表达均显著升高,其高表达可能与皮肤鳞状细胞癌发生和发展有关。 Objective To explore the expression of MIC-1 ,uPA protein in cutaneous squamous cell carcinoma(CSCC) and analyse their correlation ship with histological grade, location. Methods SP immunohistochemieal method was used to detect the expression of MIC-1, uPA protein in 42 cases of CSCC tissue and 42 cases of normal skin tissue. Then analyze their correlation with histological grade and location. Results The positive expression rates of MIC-1 (66.67%) and uPA(78.57% ) protein in CSCC were obviously higher than those in normal skin (positive expression ratios: 16.67% and 28.57% ) , and there were significant differences be- tween 2 groups ( both P 〈 0.05 ). The positive expression rate of MIC-1 and uPA were both closely correlated with the histological grade in CSCC ( both P 〈 0.05 ) and there was positive correlation between MIC-1 and uPA protein expression( P 〈 0.05 ). Conclusion The expression of MIC-1 and uPA protein increased in CSCC tissue,which suggests their over-expression may be related to oneogenesis and development of CSCC.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2012年第12期1071-1074,共4页 The Chinese Journal of Dermatovenereology
基金 河南省教育厅自然科学研究计划项目(2011A320017) 河南省卫生科技创新型人才工程专项经费(201004159) 新乡医学院重点研究领域招标课题资助(ZD2011-25)
关键词 MIC-1 UPA 皮肤鳞状细胞癌 免疫组化 MIC-1 uPA Cutaneous squamous cell carcinoma Immunohistochemistry
  • 相关文献

参考文献16

  • 1Carstensen M, Herder C', Brunner E J, et al. Macrophage inhibitory cyto- kine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes:the Whitehall II study [J]. Eur J Endocrinol,2010,162(5) :913 -917.
  • 2Noskova V, Ahmadi S, Asander E, et al. Ovarian cancer cells stimulate uPA gene expression in fibroblastic stromal cells via multiple paracrine and autocrine mechanisms[ J ]. Gynecol Onco1,2009,115 ( 1 ) : 121 - 126.
  • 3高冬玲,李晟磊,陈奎生,赵志华,赵秋民,刘宗文,张云汉.金属蛋白酶抑制基因RECK在食管鳞癌中的表达及生物学意义[J].世界华人消化杂志,2008,16(15):1634-1638. 被引量:20
  • 4Venza M,Catalano T,Visalli M,et al. Association of the DSS1 c. 143G > A polymorphism with skin squamous cell carcinoma[ J]. J Invest Der- matol,2010,130(6) :1719 - 1725.
  • 5Goan YG,Chang HC ,Hsu HK,et al. An audit of surgical outcomes of e- sophageal squamous cell carcinoma [ J ]. Eur J Cardiothorac Surg,2007, 31(3) :536 -544.
  • 6Hayes VM, Severi G, Southey MC, et al. Macrophage inhibitory cytokine- 1 H6D polymorphism,prostate cancer risk ,and survival[ J]. Cancer Ep- idemiol Biomarkers Prey,2006,15 ( 6 ) : 1223 - 1225.
  • 7Liu T, Bauskin AR, Zaunders J, et al. Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells [ J]. Cancer Res,2003,63 ( 16 ) :5034 - 5040.
  • 8王志宇,杨渤彦,高健,韩强,毕雪冰,程魏,朱熹珍.直肠癌中MIC-1,VEGF和P53表达的临床意义[J].世界华人消化杂志,2007,15(19):2170-2173. 被引量:5
  • 9Skipworth R J, Deans DA, Tan BH, et al. Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutri- tional status or survival in oesophago-gastric cancer [ J ]. Br J Cancer, 2010,102(4) :665 -672.
  • 10Brown DA, Lindmark F, Stattin P, et al. Macrophage inhibitory cytokine 1 : a new prognostic marker in prostate cancer[J]. Clin Cancer Res, 2009,15 (21) :6658 - 6664.

二级参考文献12

  • 1曹学全,张红,娄欣,孙淼淼,高冬玲,张岚,宋一民,陈奎生.食管鳞癌组织中Syndecan-1蛋白及mRNA表达[J].郑州大学学报(医学版),2007,42(1):1-4. 被引量:9
  • 2李晟磊,赵秋民,刘宗文,赵志华,高冬玲,郑湘予,陈奎生,张云汉.食管鳞癌中RECK和MMP-9蛋白表达的相关性及临床病理意义[J].世界华人消化杂志,2007,15(10):1082-1086. 被引量:34
  • 3Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767
  • 4Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM, Breit SN. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A 1997; 94: 11514-11519
  • 5Schober A, Bottner M, Strelau J, Kinscherf R, Bonaterra GA, Barth M, Schilling L, Fairlie WD, Breit SN, Unsicker K.Expression of growth differentiation factor-15/ macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult,and injured rat brain. J Comp Neurol 2001; 439: 32-45
  • 6Brown DA, Ward RL, Buckhaults P, Liu T, Romans KE, Hawkins NJ, Bauskin AR, Kinzler KW, Vogelstein B, Breit SN. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res 2003; 9:2642-2650 5 Liu T, Bauskin AR, Zaunders J, Brown DA, Pankhurst S, Russell PJ, Breit SN. Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res 2003; 63: 5034-5040
  • 7Liu T, Bauskin AR, Zaunders J, Brown DA, Pankhurst S, Russell PJ, Breit SN. Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res 2003; 63: 5034-5040
  • 8Tan M, Wang Y, Guan K, Sun Y. PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway. Proc Natl Acad Sci U S A 2000; 97: 109-114
  • 9Kieser A, Weich HA, Brandner G, Marme D, Kolch W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 1994; 9: 963-969
  • 10Breier G, Blum S, Peli J, Groot M, Wild C, Risau W, Reichmann E. Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis. Int J Cancer 2002; 97: 142-148

共引文献23

同被引文献43

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2漆楚波,朱润庆,夏和顺,王明伟.组织芯片简易制作方法及免疫组化有效性分析[J].肿瘤防治研究,2007,34(8):629-632. 被引量:17
  • 3郑雪莲,李汉贤,黄雄辉,王淑华,贺晓辉,叶蓉.组织蛋白酶D在皮肤鳞状细胞癌、基底细胞癌和脂溢性角化病的组织表达及其意义[J].中国麻风皮肤病杂志,2007,23(8):655-657. 被引量:3
  • 4Bauskin A R, Brown D A, Kuffner T, et al. Role of macrophageinhibitory cytokine-1 in tumorigenesis and diagnosis of cancer[J]. Cancer Res, 2006,66(10):4983-4986.
  • 5Mimeault M, Batra S K. Divergent molecular mechanismsunderlying the pleiotropic functions of macrophage inhibitorycytokine-1 in cancer [J]. J Cell Physiol, 2010,224(3):626-635.
  • 6Vafihara P, Hampl A, Kozubik A, et al. Growth/differentiation factor-15: prostate cancer suppressor or promoter[J]. Prostate Cancer Prostatic Dis, 2012,15(4):320-328.
  • 7Zhang L, Yang X, Pan H Y, et al. Expression of growthdifferentiation factor 15 is positively correlated withhistopathological malignant grade and in vitro cell proliferationin oral squamous cell carcinoma [J]. Oral Oncol,2009,45(7):627-632.
  • 8Schiegnitz E,Kammerer P W, Koch F P et al. GDF 15 as ananti-apoptotic, diagnostic and prognostic marker in oralsquamous cell carcinoma [J]. Oral Oncol, 2012,48 (7) :608-614.
  • 9Hanahan D,Weinberg R A. Hallmarks of cancer: the nextgeneration [J]. Cell,2011,144(5) :646-674.
  • 10Brown DA, Hance KW, Rogers C J, et al. Serum macrophage inhibitory, cytokine-1 (MIC-1/GI)FIS): a potential screening tool for the prevention of colon cancer [J]?. Cancer Epidemiol Biomarkers Prev, 2012,21 (2) : 337-346.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部